Signum Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Signum Biosciences's estimated annual revenue is currently $3.3M per year.
- Signum Biosciences's estimated revenue per employee is $155,000
Employee Data
- Signum Biosciences has 21 Employees.
- Signum Biosciences grew their employee count by -12% last year.
Signum Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director Facilities | Reveal Email/Phone |
2 | Director Research and Development | Reveal Email/Phone |
Signum Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.5M | 55 | -21% | N/A | N/A |
#2 | $0.2M | 1 | 0% | N/A | N/A |
#3 | $8.5M | 55 | -29% | N/A | N/A |
#4 | $108.5M | 500 | 2% | N/A | N/A |
#5 | $0.8M | 5 | 0% | N/A | N/A |
#6 | $0.6M | 4 | 0% | N/A | N/A |
#7 | $14.7M | 68 | -23% | $206.4M | N/A |
#8 | $492.2M | 1503 | -15% | $568M | N/A |
#9 | $1.1M | 7 | -42% | N/A | N/A |
#10 | $4.5M | 29 | 0% | N/A | N/A |
What Is Signum Biosciences?
Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from our phosphatase platform to modulate signal transduction imbalances. Signum’s phosphatase technology provides many opportunities for the development of novel pharmaceutical therapeutics. Signum has established a robust IP portfolio in the area of Signal Transduction Modulators (STMs). Signal transduction networks that regulate cellular activities have built-in global control mechanisms to coordinate their many interacting components. Signum has identified agents that perturb the two most central of these global regulatory mechanisms: G-Protein-Mediated membrane receptor signaling and Protein phosphorylation. G-Protein modulators (GPMs) regulate virtually all G-protein-mediated signaling activities and Phospho-Protein modulators (PPMs) regulate protein kinase phosphorylation networks. GPMs and PPMs can be used as cosmetics and dietary supplements to correct stressful imbalances that can be detrimental to health and well-being.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Princeton
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 21 | -38% | N/A |
#2 | $2.1M | 21 | -16% | N/A |
#3 | $3.7M | 21 | -5% | N/A |
#4 | $2.4M | 21 | 5% | N/A |
#5 | $3.4M | 21 | 0% | N/A |